26
Views
0
CrossRef citations to date
0
Altmetric
Articles on non-clinical health writing

Nanoapplications – From geckos to human health

References

  • Ge L, Sethi S, Ci L, Ajayan PM, Dhinojwala A. Carbon nanotube-based synthetic gecko tapes. Proc Natl Acad Sci USA 2007;104(26):10792–5.
  • European Commission. Definition of nanomaterials (2011) [cited 2014 Feb 11]. Available from: http://ec.europa.eu/nanotechnology/policies_en.html.
  • Caldorera-Moore M, Guimard N, Shi L, Roy K. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv 2010;7(4):479–95.
  • Mody VV, Siwale R, Singh A, Mody HR. Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2010;2(4):282–9.
  • Li W, Zhao M, Ke C, Zhang G, Zhang L, Li H, et al. Nano polymeric carrier fabrication technologies for advanced antitumor therapy. Biomed Res Int 2013;2013:305089.
  • Han Z, Conley SM, Naash MI. AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci 2011;52(6):3051–9.
  • Raula J, Lehtimäki M, Karppinen M, Antopolsky M, Jiang H, Rahikkala A, et al. Preparation of amino acid nanoparticles at varying saturation conditions in an aerosol flow reactor. J Nanopart Res 2012;14:986.
  • Beutner R, Michael J, Schwenzer B, Scharnweber D. Biological nano-functionalization of titanium-based biomaterial surfaces: a flexible toolbox. J R Soc Interface 2010;7 (Suppl 1):S93–105.
  • Laroui H, Geem D, Xiao B, Viennois E, Rakhya P, Denning T, et al. Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles. Mol Ther 2014;22(1):69–80.
  • Dick K, Dhanasekaran T, Zhang Z, Meisel D. Size-dependent melting of silica-encapsulated gold nanoparticles. J Am Chem Soc 2002;124(10):2312–7.
  • Rizzo LY, Theek B, Storm G, Kiessling F, Lammers T. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol 2013;24(6):1159–66.
  • Eustis S, el-Sayed MA. Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem Soc Rev 2006;35(3):209–17.
  • Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res 2011;44(10):947–56.
  • Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 2012;46(4):2242–50.
  • Smijs TG, Pavel S. Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness. Nanotechnol Sci Appl 2011;4:95–112.
  • Lomer MC, Thompson RP, Powell JJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 2002;61(1):123–30.
  • Maeda H. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc Jpn Acad Ser B Phys Biol Sci 2012;88(3):53–71.
  • European Medicines Agency. Abraxane® – summary of product characteristics (2014) [cited 2014 Feb 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000778/WC500020435.pdf.
  • European Medicines Agency. Myocet® – summary of product characteristics (2014) [cited 2014 Feb 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000297/WC500031811.pdf.
  • O'Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 2004;15(3):440–9.
  • Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 2005;23(31):7794–803.
  • Lerch S, Dass M, Musyanovych A, Landfester K, Mailander V. Polymeric nanoparticles of different sizes overcome the cell membrane barrier. Eur J Pharm Biopharm 2013;84(2):265–74.
  • Tinkle S, McNeil SE, Muhlebach S, Bawa R, Borchard G, Barenholz YC, et al. Nanomedicines: addressing the scientific and regulatory gap. Ann N Y Acad Sci 2014;1313(1):35–56.
  • Senjen R. Nanomedicine – new solutions or new problems? (2013) [cited 2014 May 26]. Available from: https://noharm-europe.org/sites/default/files/documents-files/2462/HCWH%20Europe%20Nanoreport.pdf.
  • Smita S, Gupta SK, Bartonova A, Dusinska M, Gutleb AC, Rahman Q. Nanoparticles in the environment: assessment using the causal diagram approach. Environ Health 2012;11 (Suppl 1):S13.
  • Qu X, Alvarez PJ, Li Q. Applications of nanotechnology in water and wastewater treatment. Water Res 2013;47(12):3931–46.
  • Giraldo JP, Landry MP, Faltermeier SM, McNicholas TP, Iverson NM, Boghossian AA, et al. Plant nanobionics approach to augment photosynthesis and biochemical sensing. Nat Mater 2014;13(4):400–8.
  • Cedervall T, Hansson LA, Lard M, Frohm B, Linse S. Food chain transport of nanoparticles affects behaviour and fat metabolism in fish. PLoS ONE 2012;7(2):e32254.
  • Rico CM, Majumdar S, Duarte-Gardea M, Peralta-Videa JR, Gardea-Torresdey JL. Interaction of nanoparticles with edible plants and their possible implications in the food chain. J Agric Food Chem 2011;59(8):3485–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.